TP53 and melanoma: CDKN1A only slightly increased in WM35 but not in WM35-R indicating that trametinib-induced G1 arrest was mainly p53/p21-independent, which is consistent with a previous report that MEK inhibition in melanoma cells resulted in p27 regulated G1 arrest rather than via p21 [34].